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The mitochondrion of Trypanosoma brucei does not encode any
tRNAs. This deﬁciency is compensated for by the import of a small
fraction of nearly all of its cytosolic tRNAs. Most trypanosomal
aminoacyl-tRNA synthetases are encoded by single-copy genes,
suggesting the use of the same enzyme in the cytosol and mito-
chondrion. However, the T. brucei genome contains two distinct
genes for eukaryotic tryptophanyl-tRNA synthetase (TrpRS). RNA
interference analysis established that both TrpRS1 and TrpRS2 are
essential for growth and required for cytosolic and mitochondrial
tryptophanyl-tRNA formation, respectively. Decoding the mito-
chondrial tryptophan codon UGA requires mitochondria-speciﬁc
C3URNAediting in the anticodon of the imported tRNATrp. In vitro
charging assays with recombinant TrpRS enzymes demonstrated
that the edited anticodon and the mitochondria-speciﬁc thiolation
of U33 in the imported tRNATrp act as antideterminants for the
cytosolic TrpRS1. The existence of two TrpRS enzymes, therefore,
can be explained by the need for a mitochondrial synthetase with
extended substrate speciﬁcity to achieve aminoacylation of the
imported thiolated and edited tRNATrp. Thus, the notion that, in an
organism, all nuclear-encoded tRNAs assigned to a given amino
acid are charged by a single aminoacyl-tRNA synthetase, is not
universally valid.
genetic code  mitochondria  RNA editing  aminoacyl-tRNA synthetase
In animal and most fungal mitochondria, the total set of tRNAsrequired for translation is encoded in the mitochondrial genome
and, therefore, of bacterial evolutionary origin. The aminoacyl-
tRNA synthetases (aaRSs) responsible for charging of mitochon-
drial tRNAs always are nuclear-encoded and, therefore, need to be
imported intomitochondria (1).However, their evolutionary origin,
just as the one of their substrate tRNAs, is in most cases bacterial.
Thus eukaryotes, if we exclude all plastid-containing organisms,
generally have two sets of aaRSs, one for cytosolic and a second one
for mitochondrial aminoacyl-tRNA synthesis. In most eukaryotes,
however, there are a few aaRSs that are targeted to both the cytosol
and the mitochondria, indicating that the two sets of enzymes
overlap to a limited extent (2).
Most mitochondrial genetic systems show deviations from the
universal genetic code. The most common one is a reassignment of
the termination codonUGA to tryptophan (3). Thus, to decode the
UGA tryptophan codon, mitochondria require a nonstandard
tRNATrp carrying a UCA instead of CCA anticodon. Cytosolic
tRNATrpCCA is aminoacylated by a eukaryotic tryptophanyl-tRNA
synthetase (TrpRS) (4), whereas the mitochondrial-encoded
tRNATrpUCA is charged by a bacterial-type TrpRS (5). The CCA
anticodon is a known identity element for both enzymes (6–8). It
is clear, however, that the bacterial-type enzyme in mitochondria
must be able to tolerate an UCA anticodon (5).
In contrast to animals and most fungi, mitochondria from
protozoa and plants generally lack a variable number of mito-
chondrial tRNA genes. In these cases, the missing tRNAs are
replaced by import of a small fraction of the corresponding
nuclear-encoded cytosolic tRNAs (9). As a consequence, the
imported tRNAs are always of a eukaryotic evolutionary origin.
An intriguing situation is found in trypanosomatids, e.g.,
Trypanosoma brucei and Leishmania spp., which have lost all
mitochondrial tRNA genes (10–12). Their mitochondrial trans-
lation system therefore must function exclusively with imported
eukaryotic-type tRNAs.
Trypanosomatid mitochondria use UGA as tryptophan codon.
However, the only tRNATrp gene in T. brucei is nuclear and carries
the standard tryptophan anticodon CCA. Recent work in Leish-
mania revealed that trypanosomatids use RNA editing to convert
theCCAanticodon of40%of the imported tRNATrp toUCA; the
resulting tRNAnow is able to recognizeUGA codons (13). Besides
RNA editing, the imported tRNATrp is subjected to additional
mitochondria-specific modifications; most importantly, the thiola-
tion of U33, the ‘‘universally unmodified’’ uridine in all known
tRNAs (14). tRNA editing is not required for thiolation of U33 but
it is possible that the modification is needed for editing. In any case,
the close proximity of the thiolated U33 to the anticodon suggests
that it influences decoding.
Cytosolic and mitochondrial tRNAs of trypanosomatids orig-
inate from the same set of nuclear genes. Therefore, it is
reasonable to assume that the same aaRSs are used in the cytosol
and in mitochondria. This assumption is supported by the fact
that in T. brucei, most aaRSs are represented by single genes only
(15). Furthermore a dual localization in the cytosol and in
mitochondria has been shown for T. brucei glutaminyl-tRNA
synthetase and the glutamyl-tRNA synthetase (16). The im-
ported trypanosomal tRNATrp, however, represents a special
case, because its anticodon loop, due to the editing event and the
thiolation of U33, differs from its cytosolic counterpart (14).
This situation raises the question of how cytosolic and mito-
chondrial tryptophanyl-tRNA species are formed in T. brucei?
Here we show that unlike most other trypanosomal tRNAs,
because of the mitochondrial use of UGA as tryptophan codon,
cytosolic and mitochondrial aminoacylation of tRNATrp requires
two distinct eukaryotic-type TrpRSs.
Results
The T. brucei Genome Encodes Two Eukaryotic TrpRSs. In the genome
of Saccharomyces cerevisiae, probably the best characterized eu-
karyote, we find annotated genes for 36 different aaRSs (www.
yeastgenome.org). These enzymes can be divided into 16 cytosol-
specific ones, 14 of which are specific formitochondria, and four are
known to be doubly targeted to the cytosol and the mitochondria
(these numbers are still, in part, based onpredictions and, therefore,
represent approximations). It is striking to compare yeast with T.
Abbreviations: aaRS, aminoacyl-tRNA synthetase; OXPHOS, oxidative phosphorylation;
RNAi, RNA interference; TrpRS, tryptophanyl-tRNA synthetase.
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brucei, whose genome encodes only 23 annotated aaRSs (15). This
low number makes sense because the tRNAs in the cytosol and
mitochondria derive from the same nuclear genes (10); it therefore
can be expected that the same aaRSs are used in both compart-
ments. Nevertheless, two distinct genes are found for aspartyl-
tRNA synthetase, lysyl-tRNA synthetase, and TrpRS. Further-
more, in each case, one of the two proteins is predicted to have a
mitochondrial targeting sequence. It is not obvious why T. brucei
should have two aspartyl- or lysyl-tRNA synthetases, because the
corresponding cytosolic and mitochondrial substrate tRNAs de-
rived from the same nuclear genes. However, the need for two
distinct TrpRSs might be explained by the fact that because of
editing in the mitochondrion, cytosolic andmitochondrial tRNATrp
differ in an anticodon nucleotide (13). In this study, we focus on the
functional analysis of Tb-TrpRS1 and Tb-TrpRS2, the two trypano-
somal TrpRS homologues. The two proteins are 41% identical,
phylogenetic analysis shows that both are of the eukaryotic type,
and Tb-TrpRS2 contains a predicted 50-aa mitochondrial prese-
quence (Fig. 1). Tb-TrpRS1 shares 48–53% sequence identity to
eukaryotic TrpRSs, whereas Tb-TrpRS2 is more diverged, showing
an identity to other eukaryotic TrpRSs of only 39–41%. Interest-
ingly, essentially the same situation is found inLeishmania (17). The
two leishmanial proteins Lm-TrpRS1 and Lm-TrpRS2 are 76%
and 59% identical to their trypanosomal counterparts.
Intracellular Localization of Tb-TrpRS1 and Tb-TrpRS2. Tb-TrpRS2 is
predicted to have a mitochondrial targeting signal. However, in
T. brucei, such predictions are difficult because mitochondrial
presequences can be very short (18). Thus, to determine the
localization of the two enzymes, we prepared transgenic cell
lines, allowing inducible expression of Tb-TrpRS1 and Tb-
TrpRS2 versions carrying the 10-aa-long Ty1-peptide as epitope
tags at their carboxyl termini (19). Immunofluorescence analysis
by using an anti Ty1-antibody showed a tetracycline-inducible
diffuse staining of the tagged Tb-TrpRS1, consistent with a
cytosolic localization (Fig. 2A Top and Center). For tagged
Tb-TrpRS2, on the other hand, a staining identical to the one
seen with the mitochondrial marker was obtained (Fig. 2A
Bottom). Furthermore, the two transgenic cell lines were sub-
jected to a biochemical analysis that showed that the tagged
Tb-TrpRS1 copurifies with the cytosolic marker, whereas the
tagged Tb-TrpRS2 together with the mitochondrial marker is
recovered in the pellet (Fig. 2B). These results are consistent
with the immunofluorescence analysis and show that the two
TrpRSs have a nonoverlapping intracellular distribution: Tb-
TrpRS1 is exclusively cytosolic and Tb-TrpRS2 is exclusively
mitochondrially localized.
RNA Interference (RNAi)-Mediated Ablation of Tb-TrpRS1 and Tb-
TrpRS2. To determine the function of Tb-TrpRS1 and Tb-TrpRS2,
we established two stable transgenic cell lines, which allow tetra-
Fig. 1. T. brucei contains two eukaryotic TrpRSs. (A) Multiple sequence
alignment of the cytosolic TrpRS from S. cerevisiae (ScWRS1) and the two T.
brucei orthologues (Tb-TrpRS1 and Tb-TrpRS2). The sequences were aligned
by using the CLUSTAL W program with default parameters. Strictly conserved
residues and conservative replacements are shown in black and gray boxes,
respectively. (B) Position of the two trypanosomal enzymes Tb-TrpRS1 (Tb1)
and Tb-TrpRS2 (Tb2) in a phylogenetic tree based on a multiple sequence
alignment of the cytosolic TrpRS from mouse [Mus musculus (Mm)], Drosoph-
ilamelanogaster (Dm), andyeast [S. cerevisiae (Sc)]; themitochondrial enzyme
of yeast (Sc mito) and mouse (Mm mito); and, indicated by gray letters, the
TrpRS from the bacteria Corynebacterium glutamicum (Cg), Bacillus subtilis
(Bs), and E. coli (Ec). The tree was constructed by using TREEVIEW, which is
available on http:taxonomy.zoology.gla.ac.ukrodtreeview.html.
Fig. 2. Localization of trypanosomal TrpRSs. (A Top and Center) Double
immunoﬂuorescence analysis of a T. brucei cell line expressing Tb-TrpRS1
carrying the Ty1 tag at its carboxyl terminus under the control of the tetra-
cycline-inducible (Tet and Tet) procyclin promoter. The cells were stained
for DNAby usingDAPI, for a subunit of the ATPase, serving as amitochondrial
marker andwith amonoclonal antibody recognizing the Ty1-Tag. (A Bottom)
Same as Top and Center, but a cell line expressing carboxyl-terminally Ty1-
tagged Tb-TrpRS2 was analyzed. (Scale bars: 10 m.) (B) Immunoblot analysis
of total cellular (T), crude cytosolic (C), and crude mitochondrial extracts (M)
for the presence of the Ty1-tagged Tb-TrpRS1 and Tb-TrpRS2, respectively.
Elongation factor 1a (EF-1a) served as a cytosolic and -ketoglutarate dehy-
drogenase (KDH) as a mitochondrial marker.
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cycline-inducible ablation of each of the two enzymes. The North-
ern blot insets in Fig. 3 A and B show that induction of RNAi in
these two cell lines leads to specific degradation of the correspond-
ing Tb-TrpRS mRNAs. Most importantly, concomitant with the
depletion of the mRNAs, a growth arrest is observed 2 (for
Tb-TrpRS1) and 3 days (for Tb-TrpRS2) after the addition of
tetracycline (Fig. 3 A and B). Thus, Tb-TrpRS1 and Tb-TrpRS2 are
both essential for growth of insect stage T. brucei.
To determine the biochemical phenotype of the twoRNAi cell
lines, we isolated total and mitochondrial RNA from untreated
cells and from cells grown in the presence of tetracycline.
Subsequently, the RNAs were resolved on long acid urea poly-
acrylamide gels (20), followed by Northern blot analysis, to
determine the ratio of uncharged tRNATrp to tryptophanyl-
tRNAsTrp (Fig. 3 C and D). The results in Fig. 3C Left show that
ablation of Tb-TrpRS1 results in the accumulation of uncharged
cytosolic tRNATrp. Interestingly, in measurements of the levels
of tryptophanyl-tRNATrp in the induced Tb-TrpRS2 cell line, the
converse result was obtained, and a selective accumulation of
deacylated mitochondrial tRNATrp was observed (Fig. 3D Right).
As expected, ablation of either TrpRS had no influence on the
aminoacylation levels of cytosolic tRNALeu or mitochondrial
tRNATyr. These results show that, in agreement with its exclusive
cytosolic localization, Tb-TrpRS1 is responsible for aminoacy-
lation of the cytosolic tRNATrp. On the other hand Tb-TrpRS2,
in line with its mitochondrial localization, is required for charg-
ing of imported mitochondrial tRNATrp.
Ablation of Tb-TrpRS2 abolishes mitochondrial protein syn-
thesis and, consequently, is expected to interfere with oxidative
phosphorylation (OXPHOS). Mitochondria produce ATP, by
OXPHOS and by substrate level phosphorylation linked to the
citric acid cycle. We recently established an assay that allows
quantitation of both modes of ATP production in isolated T.
brucei mitochondria (21, 22). To measure antimycin-sensitive
OXPHOS, mitochondria are incubated with ADP and succinate.
-ketoglutarate is used in the determination of the antimycin-
resistant substrate level phosphorylation, whereas atractyloside
treatment that prevents mitochondrial import of the added ADP
is the control. The results in Fig. 4 show that ablation of
Tb-TrpRS2 selectively knocks down OXPHOS that, in part,
depends on mitochondrial-encoded proteins but does not inter-
fere with substrate level phosphorylation, which depends solely
on nuclear encoded proteins.
Substrate Specificities of Tb-TrpRS1 and Tb-TrpRS2. Recent work in
Leishmania (14) showed that the imported tRNATrp is present in
two main forms: (i) the tRNATrpCCA carrying a mitochondria-
specific methylation on the C34 and (ii) the tRNATrpUCA in which
the methylated C34 has been edited to a methylated U and which
also contains a mitochondria-specific thiolated U33. Furthermore,
it was shown that both tRNATrp forms contain a mitochondria-
specific methylation on the 32 (Fig. 5A). Fig. 5B shows that in T.
brucei 85% of the imported tRNATrp is thiolated. Furthermore,
RT-PCR analysis by using cytosolic and mitochondrial RNA as
substrates demonstrates that 40% of mitochondrial tRNATrp is
edited (Fig. 5C). Thus, in contrast to Leishmania, where all thio-
lated tRNATrp is edited (14), there is a population of T. brucei
tRNATrp, which is thiolated but not edited.
To test their substrate specificities, recombinant proteins of
Fig. 3. Tb-TrpRS1 and Tb-TrpRS2 are essential for the growth of procyclic T.
brucei and are responsible for formation of tryptophanyl-tRNA in the cytosol
and the mitochondria, respectively (A) Growth curve in the presence and
absence of tetracycline (Tet and Tet) of a representative clonal T. brucei
RNAi cell line ablated for Tb-TrpRS1. (A Inset) A Northern blot for Tb-TrpRS1
mRNA. The time of sampling is indicated by the arrow. The rRNAs in the lower
panel serve as loading controls. (B) Same as A for an RNAi cell line ablated for
Tb-TrpRS2. (C) Northern blot analysis of total andmitochondrial RNA isolated
under acidic conditions from the Tb-TrpRS1 RNAi cell line. The total RNA
fraction only contains 5% of mitochondrial RNA and, thus, essentially rep-
resents cytosolic RNA. Days of induction (0 and 3) by tetracycline are indicated
at the bottom. The blots were probed for the T. brucei tRNATrp as well as
tRNALeu and tRNATyr, which serve as controls not affected by the RNAi. The
RNA fractionswere resolved on long acid urea gels, which allow separation of
aminoacylated from deacylated tRNAs. The bar graph shows the quantiﬁca-
tion of the results. Relative amounts of aminoacylated tRNAs are indicated for
the tRNATrp and the controls (tRNALeu and tRNATyr), respectively. For each lane,
the sum of aminoacylated and deacylated tRNA was set to 100%. (D) Same as
C, but analysis was done for the Tb-TrpRS2 RNAi cell line.
Fig. 4. Ablation of Tb-TrpRS2 selectively abolishes OXPHOS. Succinate and
-ketoglutarate mitochondrial ATP production in crude mitochondrial frac-
tions of the Tb-TrpRS2 RNAi cell line. Uninduced cells (Tet) are shown on the
left, and induced cells (Tet) are shown on the right of the graphs. The
substrate tested is indicated at the top, and additions of antimycin (antim.)
and atractyloside (atract.) are indicated at the bottom. ATP productions in
mitochondria isolated from uninduced cells tested without antimycin or
atractyloside are set to 100%. The bars representmeans expressed as percent-
ages from three or more independent inductions. SEs are indicated.
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Tb-TrpRS1 and Tb-TrpRS2 were overexpressed in Escherichia coli
and purified to95%homogeneity. In vitro charging assays showed
that although neither enzyme was able to recognize in vitro tran-
scripts corresponding to unedited or edited tRNATrp (data not
shown), both efficiently aminoacylated isolated T. brucei cytosolic
tRNA (Fig. 5D Left). Thus, the cytosolic unedited tRNATrpCCA can
be charged with very similar efficiencies by both the cytosolic and
the mitochondrial enzyme. Interestingly, however, when using
isolated mitochondrial tRNAs as a substrate, the level of amino-
acylation achieved by the cytosolic Tb-TrpRS1 dropped to 19% of
that obtained with the mitochondrial enzyme (Fig. 5D Center
Right). This fraction correlates with the level of nonthiolated
mitochondrial tRNATrp (Fig. 5B), suggesting that, in contrast to
mitochondrial Tb-TrpRS2, Tb-TrpRS1 is not able to charge thio-
lated tRNATrp. Fig. 5B shows that hydrogen peroxide treatment
produces a mitochondrial tRNATrp population in which only 15%
(instead of 85%) of the molecules contain thiolated U33. Interest-
ingly, the H2O2-treated mitochondrial tRNA fraction can be
charged by cytosolic Tb-TrpRS1 to a level that corresponds to
40%of the one observed with themitochondrial enzyme (Fig. 5D
Right). However, the reactivity of either enzyme did not change
when tested with H2O2-treated cytosolic tRNAs, which do not
contain thiolated tRNATrp (Fig. 5D Center Left). Thus, removing
the thio group converts a population ofmitochondrial tRNATrp into
a substrate for the cytosolic Tb-TrpRS1. Interestingly, even in the
absence of thiolated U33, 60% of the mitochondrial tRNATrp
remained refractory to aminoacylation by the cytosolic enzyme.
The uncharged fraction represents 50% of the thiolated U33
lacking tRNATrp population and, thus, is similar to the 40%
observed for the edited population. Therefore, the most parsimo-
nious explanation of these results is that the edited U34, just as the
thiolated U33, both act as independent antideterminants for cyto-
solic Tb-TrpRS1. To confirm the charging results presented above,
we expressed the T. brucei tRNATrpUCA and tRNATrpCCA genes in
E. coli and isolated total tRNA. Aminoacylation of these tRNA
samples with the two TrpRSs demonstrated (Fig. 5E) that the
mitochondrial Tb-TrpRS2 enzyme charged both tRNATrp isoac-
ceptors, whereas the cytosolic Tb-TrpRS1 acylated only
tRNATrpCCA. Neither enzyme charged E. coli tRNA. Thus, Tb-
TrpRS2 efficiently aminoacylates the unedited and edited fraction
ofmitochondrial tRNATrp. Furthermore, the in vivo aminoacylation
level of total mitochondrial tRNATrp was shown to be close to 80%
(Fig. 3D). These results suggest that both isoacceptors are used in
mitochondrial protein synthesis, the unedited tRNATrp being re-
stricted to decode the standard UGG tryptophan codons.
Our current understanding of the structure of eukaryotic
TrpRS does not allow a prediction of the anticodon binding sites
that might explain the different tRNA recognition properties.
Based on structural modeling of human TrpRS (D. Kennedy and
W. Yin, unpublished data), the putative anticodon-binding
domain of Tb-TrpRS1 extends from G270-F373. The sequences
of the two Tb-TrpRSs are quite different in this region; they
share only 30% amino acid identity.
Discussion
One of the few generalizations about mitochondrial tRNA
import states that only a small fraction of a given nuclear
encoded tRNA is imported and that the remainder functions in
cytosolic translation (9). Thus, in all organisms, imported tRNAs
are always of the eukaryotic type. Mitochondrial translation,
however, is of a bacterial evolutionary origin. tRNA import,
therefore, can be considered as a horizontal gene product
transfer between the eukaryotic and bacterial domains. There
are some fundamental differences between eukaryotic and
bacterial-type translation systems that, for some tRNAs, are
expected to prevent the dual use in the cytosol and in mitochon-
dria. One such difference is necessitated by mitochondrial
variants of the genetic code. The most frequent code deviation
Fig. 5. Tb-TrpRS1 and Tb-TrpRS2 have distinct substrate speciﬁcities. (A) Mito-
chondrial editing and modiﬁcation events of the anticodon loop of the tRNATrp
asdescribed forLeishmania (14). Thepercentagesof the thiolatedU (s2U)and the
C3U editing as determined for T. brucei tRNATrp are indicated. (B Left) The
percentageof thiomodiﬁedmitochondrial tRNATrp of T. bruceiwasmeasuredby
N-acryloylaminophenylmercuric chloride gel electrophoresis (33) and Northern
blot hybridization. The shifted band represents thiolated tRNATrp(S2U). (B Right)
Thefractionofthiolatedmitochondrial tRNATrp thatremainsthiolatedafterH2O2
treatment was determined as in the left lane. (C) Quantitative RT-PCR assay for
edited tRNATrp. (C Upper) The cytosolic and mitochondrial tRNA fractions that
were used as templates are free of DNA. (C Lower) The blot shows that RNA
editing canbeanalyzedby a restrictiondigest because it destroys aHinfI site that
is present in the cDNA derived from the unedited tRNATrp (14). Introduction of a
synthetic HinfI plus 20 ﬂanking nucleotides at the 5 end of the 5 RT-PCR primer
provides an internal control for the HinfI digestion, allowing the quantitative
determination of RNA editing. cDNA ampliﬁed from unedited tRNATrp contains
twoHinfI sites and, thus,will be digested into three fragments (46, 22, and 21 nt;
unedited).ThecDNAderivedfromeditedtRNATrp contains thesyntheticHinfI site
only and will be digested into two fragments (68 and 21 nt; edited). Measuring
the intensities of the diagnostic bands for nonedited (46 nt) and edited (68 nt)
tRNATrpallows,aftercorrectingfor theirdifferentmolecularmass,determination
of the fraction of edited tRNATrp in T. brucei mitochondria. (D) In vitro amino-
acylation assays by using [3H]tryptophan and recombinant Tb-TrpRS1 as well as
Tb-TrpRS2 as enzymes. (Left and Center Left) Untreated and H2O2-treated cyto-
solic tRNA were charged. (Right and Center Right) Same as Left and Center Left
but with untreated and H2O2-treated mitochondrial tRNAs. For each graph, the
tRNA charged by the Tb-TrpRS2 was set to 100%. The percentage of mitochon-
drial tRNATrp that is thiolated in the untreated and treated fractions is indicated
onthe right. ThemeansandSE for three independentexperimentsare shownfor
aminoacylation of untreated tRNAs. For experiments using H2O2-treated tRNAs,
the mean of two experiments is shown. The two values each for cytosolic and
mitochondrial tRNAsvariedby20%and10%, respectively. (E)Aminoacylationof
T. brucei tRNATrp overexpressed inE. colibyusing200nMenzymeand0.25gl
tRNA. (Right) Tb-TrpRS1 charging of total E. coli tRNA with T. brucei tRNATrpUCA
overexpressed (■), total E. coli tRNAwith T. brucei tRNATrpCCA overexpressed (}),
and total E. coli tRNA (Œ). (Left) Tb-TrpRS2 charging of total E. coli tRNA with T.
brucei tRNATrpUCA overexpressed (■), total E. coli tRNAwith T. brucei tRNATrpCCA
overexpressed (}), and total E. coli tRNA (Œ).
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is the reassignment of the stop codon UGA to tryptophan (3).
Reading this reassigned codon requires a tRNATrp with a UCA
anticodon. Simultaneous use of this tRNA in the cytosol and in
mitochondria, however, is not possible because it would act as a
nonsense suppressor in the cytosol. In line with this constraint,
it was recently shown that in most organisms that import tRNAs
the mitochondrial tRNATrp gene has been retained (23). Thus,
it is unexpected that trypanosomatids import the tRNATrp. The
way Leishmania mitochondria accommodate the change in the
genetic code is by mitochondria-specific C3Uediting of the first
anticodon position of the imported tRNATrp (13). In the present
work, we have analyzed the situation in the closely related T.
brucei and shown that although editing of the imported tRNATrp
is necessary, it is not sufficient to allow decoding of the mito-
chondrial UGA codons. The problem that arises is that the
mitochondrially localized tRNATrp cannot be aminoacylated by
the standard eukaryotic-type TrpRS (Tb-TrpRS1). In contrast to
most other trypanosomal aaRSs, which have dual location and
are used to charge cytosolic and imported tRNAs (16), Tb-
TrpRS1 is exclusively found in the cytosol. A survey of the
genome showed that T. brucei has a second TrpRS (Tb-TrpRS2)
that is related to the cytosolic Tb-TrpRS1 but is localized
exclusively in mitochondria. This enzyme has an extended sub-
strate specificity and aminoacylates in vitro both cytosolic and
mitochondrial tRNATrp. Further studies showed that both the
thio-modified U33 and the C3U editing of the first nucleotide
in the anticodon prevent mitochondrial tRNATrp to be recog-
nized by the cytosolic Tb-TrpRS1. The function of the thiolated
U33 in mitochondrial tRNATrp of trypanosomatids is unknown
(14). However, the fact that it is localized immediately 5 of the
first position of the anticodon suggests that it influences the
decoding properties of the tRNATrp or that it even may be
required for tRNA editing. In most systems, the reassignment of
the UGA codon is accommodated by a single mutation in the
mitochondrial tRNATrp gene, which probably requires an adap-
tation of the mitochondrial TrpRS (3). The situation is different
for mitochondria of trypanosomatids because they need (i) a
mitochondria-specific tRNA editing enzyme that produces the
tRNATrpUCA (13) and (ii) a separate TrpRS (Tb-TrpRS2) with
an extended substrate specificity. The need for a record TrpRS
is due to the fact that the C3U editing not only changes the
decoding properties of the tRNATrp but also its identity toward
the classic TrpRS (Tb-TrpRS1). Thus, recoding of UGA to
tryptophan appears to be more costly for trypanosomatids than
for other organisms.
Doubly targeted aaRSs, which are able to aminoacylate both
nuclear-encoded tRNAs in the cytosol and the corresponding
mitochondrial encoded tRNAs, are found in most, if not all,
eukaryotes (2). In this study, we describe the converse situation
in that tRNAs derived from the same nuclear gene require two
distinct aaRSs for proper function. Thus, the presence of a single
modification, be it the thio group on theU33 or the C3Uediting
of the anticodon, is sufficient to prevent aminoacylation by
Tb-TrpRS1. Our results show that the notion that in an organism
all nuclear-encoded tRNA isoacceptors for a given amino acid
are charged by a single aaRS (4) is not universally valid.
The anticodon and the discriminator nucleotide are the major
identity elements for TrpRS (6, 7). Whereas the anticodon is a
phylogenetically shared identity element, the discriminator nucle-
otide differs between bacteria and eukaryotes (6), which explains
why the two TrpRSs cannot efficiently cross-aminoacylate the
corresponding tRNATrp species (24, 25). Most mitochondria de-
code UGA as tryptophan, thus it is clear that the bacterial-type
mitochondrial TrpRS has evolved to tolerate anUCAanticodon (3,
5). Interestingly, the same applies for the eukaryotic mitochondria-
localized Tb-TrpRS2 in T. brucei because, unlike the cytosolic
Tb-TrpRS1, it is able to charge eukaryotic tRNATrp carrying an
UCA anticodon. Thus, the existence of both bacterial and eukary-
otic TrpRSs that are able to chargemitochondrial tRNATrp carrying
the nonstandardUCAanticodon is a result of convergent evolution.
Whether bacterial or eukaryotic TrpRS is used insidemitochondria
might be determined to a great extent by the discriminator nucle-
otide on the corresponding tRNATrp and, therefore, depends on
whether the tRNATrp is encoded in the mitochondrial DNA or
imported from the cytosol.
Thus Tb-TrpRS2 represents an adaptation to the fact that the
trypanosomal mitochondrial translation system has to function
with eukaryotic-type tRNAs. Another adaptation of the same
kind is the unusual T. brucei methionyl-tRNAMet formyltrans-
ferase (MTF), which because of the absence of a bacterial-type
initiator tRNAMet, has to formylate the only tRNAMet present in
mitochondria, which is the imported elongator tRNAMet (26, 27).
To perform their function, the trypanosomal MTF and the
Tb-TrpRS2 had to develop a substrate specificity that is distinct
from their orthologues. Trypanosomal MTF completely
switched its specificity and exclusively formylates elongator
tRNAMet, unlike all other MTFs, which only recognize bacterial-
type initiator tRNAsMet. In the case of Tb-TrpRS2, the enzyme
still recognizes the standard substrate for eukaryotic TrpRS, the
tRNATrpCCA, but has extended its substrate specificity to
tRNAsTrp carrying a thiolated U33 and an UCA anticodon.
Studies of the adaptations of mitochondrial translation factors
that interact directly with tRNAs (e.g., aaRSs, initiation factor 2
(28), or elongation factor Tu) to imported eukaryotic tRNAs
should yield additional surprises and reveal more fundamental
requirements of translation.
Materials and Methods
Cells. Procyclic T. brucei, strain 29-13 (29) was grown in SDM-79,
supplemented with 15% FCS25 g/ml hygromycin15 g/ml
G-418 at 27°C, and harvested at 1.5–3.5  107 cells per ml.
Production of Transgenic Cell Lines. As a tag to localize Tb-TrpRS1
(accession no. Tb927.3.5580) and Tb-TrpRS2 (accession no.
Tb927.8.2240), we used a 10-aa epitope of the major structural
protein of yeast Ty1, which is recognized by the monoclonal
antibody BB2 (19). The sequences corresponding to the carbox-
yl-terminal Ty1-tagged Tb-TrpRS1 and Tb-TrpRS2 were cloned
into a derivative of pLew-100 to allow tetracycline-inducible
expression of the tagged proteins (29).
RNAi of Tb-TrpRS1 and Tb-TrpRS2 was performed by using
stem loop constructs containing the puromycin resistance gene
(22). As inserts, we used a 537-bp fragment (nucleotides 4–540)
of the Tb-TrpRS1 gene and a 537-bp fragment (nucleotides
4–540) of the Tb-TrpRS2 gene.
Transfection of T. brucei and selection with antibiotics, clon-
ing, and induction with tetracycline were done as described in
ref. 30.
Cell Fractionation by Digitonin. Fractionation of Ty1 epitope-
tagged Tb-TrpRS1- and Tb-TrpRS2-expressing cells was done by
digitonin extraction. Washed T. brucei cells (108 cells) were
resuspended in 0.5 ml of SoTE (0.6 M sorbitol20 mM TrisHCl,
pH 82 mM EDTA). After the addition of 0.5 ml of SoTE
containing 0.03% (wtvol) of digitonin, the samples were mixed
by pipetting and incubated on ice for 5 min. The suspensions
were centrifuged at 6,800 g for 5min at 4°C, resulting in a pellet
that corresponds to a crude mitochondrial fraction and a super-
natant faction. The latter was cleared by centrifugation (10 min
at 21,000 g at 4°C), yielding a crude cytosolic fraction. Finally,
0.3  107 cell equivalents each of total protein extract, crude
cytosolic, and crude mitochondrial fractions were separated by
SDS-gel electrophoresis and analyzed by immunoblotting.
Analysis of in Vivo Aminoacylation. Mitochondria from uninduced
and induced Tb-TrpRS1 and Tb-TrpRS2 RNAi cell lines were
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isolated by digitonin extraction and subsequentRNase treatment as
described to yield a crude mitochondrial fraction that is essentially
free of cytosolic RNAs (10). RNA was isolated from the crude
mitochondrial fractions as well as uninduced and induced total cells
by using the acid guanidinium isothiocyanate procedure (31), which
allows isolation of charged tRNA. Then charged tRNA was sepa-
rated from free tRNAonacid urea polyacrylamide gels as described
in ref. 20 and visualized by Northern blot hybridization with labeled
oligonucleotides (tRNATrp, TGAGGACTGCAGGGATTG;
tRNALeuCAG, CCTCCGGAGAGATGACGA; tRNATyrGUA, TG-
GTCCTTCCGGCCGGAATCGAA).
Cloning, Overexpression, and Purification of Tb-TrpRS1 and Tb-TrpRS2.
The gene sequences were PCR-amplified by using the Expand
High Fidelity PCR System (Roche Applied Science). Tb-TrpRS1
was cloned into NcoIXhoI in pET20b (Novagen) with a C-
terminal His tag. For Tb-TrpRS2, the N-terminal 21 amino acids
(mitochondrial leader sequence) were omitted, and the sequence
was cloned into the NdeIXhoI in pET15b (Novagen). After
sequence verification, the resulting plasmids were transformed
into E. coli Bl-21-CodonPlus(DE3)-RIL cells (Stratagene).
Cells were grown at 37°C in LB medium supplemented with
ampicillin (100 gml) and chloramphenicol (34 gml), and
protein expression was autoinduced by using the Overnight
Express Autoinduction System (Novagen) according to the
manufacturer’s instructions. After harvest, the cells were soni-
cated, and the proteins were purified by Ni-NTA chromatogra-
phy (Qiagen, Valencia, CA). The desired fractions were pooled,
dialyzed against 50 mM Na2HPO4, pH 8.05 mM 2-mercapto-
ethanol50% glycerol, and stored at 20°.
In Vitro Aminoacylation Assays. (i) Using native tRNA. Mitochondria
were prepared by hypotonic lysis and Percoll gradient centrifu-
gation as described in ref. 32. The supernatant obtained after the
initial lysis was used to isolate cytosolic RNAs by repeated
phenol extractions and ethanol precipitations. Mitochondrial
RNA was isolated from gradient purified mitoplasts by the acid
guanidinium isothiocyanate procedure (31). A cumulative 25-
liter T. brucei culture yielded 6 mg of mitochondrial RNA. Total
and mitochondrial RNA were deacylated in 0.3 M TrisHCl (pH
9.0) at 30°C for 1 h. Finally, tRNAs were isolated from both
fractions by using Qiagen-Tip columns as described in ref. 16.
The percentage yield of tRNAs from deacylated total and
mitochondrial RNAs was 5%. H2O2 treatment of mitochon-
drial and total tRNA was done at 0.2 mgml by using 0.21%
(wtvol) of H2O2 in 10 mM TrisHCl (pH 7.5) for 20 h at 20°C.
The reaction was stopped by adding 2-mercaptoethanol to 50
mM, and tRNAs were purified by ethanol precipitation. The
presence and absence of thiolated U33 was monitored by using
8 M urea10% polyacrylamide gels containing a 25 mM con-
centration of N-acryloylaminophenylmercuric chloride (33).
In vitro aminoacylation assay were performed in 50 mM
Hepes, pH 7.010 mM Mg-acetate2 mM ATP4 mM DTT
0.05% (wt/vol) BSA, and a mixture of 38 M cold and 2 M
[3H]tryptophan (32 Cimmol; 1 Ci 	 37 GBq). The enzyme and
tRNA concentrations used were as follows: 400 nM recombinant
Tb-TrpRS1 or Tb-TrpRS2 and 1 mgml isolated total or mito-
chondrial tRNA as substrates. Incubation was for 10 min at 37°C,
and Trp-tRNA was determined as described in ref. 34.
(ii) Using E. coli tRNA in which T. brucei tRNATrpUCA and tRNATrpCCA were
overexpressed. Reactions were carried out as described above with
the following modifications: 75.5 M cold and 4.5 M [3H]tryp-
tophan (32 Ci/mmol)200 nM TrpRS0.25 mg/ml tRNA.
Miscellaneous. Northern blots of tRNAs and ATP production
assays were done as described in refs. 10 and 22. For the RT-PCR
to amplify cDNA of cytosolic and mitochondrial tRNATrp, the
oligonucleotides used were as follows: forward primer
(AGAGAGAGCGAGGAAGGCGAGATTCTCAGTGGT-
AGAGCATTGG, containing a synthetic HinfI site) and reverse
primer (TGGTGAGGACTGCAGGGATTG).
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